If you’re thinking about investing in medtech, congratulate yourself—you’ve chosen one of the most exciting, innovative, and occasionally stomach-churning sectors out there.

But between regulatory hurdles, clinical workflow quirks, and the fact that even great ideas can wither in the wild, medtech due diligence is…well, a sport.

In a recent webinar, industry veteran Renee Franz (Lean RAQA) teamed up with venture capitalist and serial entrepreneur Mudit Jain, PhD, (Treo Ventures) to walk investors through the realities of evaluating medical device opportunities.

With over 30 years of combined experience, plus unicorn exits, hundreds of cleared devices, and several cautionary tales under their belts, their conversation is a gold mine for investors entering this space.

Subscribe to the leanRAQA Today podcast for even more bold, insightful conversations that make medtech regulation make sense.

Watch the video on YouTube: https://youtu.be/Y_QojHiu4dQ

Visit us at https://leanraqa.com/ for even moreregulatory goodness and to learn more about our services.